Pediatric Hematologist/Oncologist (Child Cancer Specialist)
Brian Stover, MD, earned his medical degree from the University of Texas Medical School at Houston. Soon after, he began his residency in pediatrics at the University of Florida and continued his career at UF, completing a fellowship in pediatric hematology/oncology.
Dr. Stover joined the UF faculty in 2019 as an assistant professor in the department of pediatrics. His current research focuses on solid tumor immunotherapy, including the use of personalized RNA-nanoparticle vaccines in metastatic osteosarcoma.
Dr. Stover is board-certified in pediatrics by the American Board of Pediatrics and is board-eligible in hematology/oncology. He is a recipient of the Henry A. Kokomoor award for Scientific Discovery and is a member of the American Academy of Pediatrics, the Children鈥檚 Oncology Group and the American Society of Pediatric Hematology-Oncology.
This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after鈥�
This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune鈥�
This phase II trial tests the safety and best dose of revumenib in combination with chemotherapy, and evaluates whether this treatment improves the outcome in infants and young children who have leukemia that has come back (relapsed) or does not鈥�
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurances鈥淢ake sure you fight." Jennifer Driggers uttered those four words to her daughter the day after Julianna was diagnosed with neuroblastoma, an aggressive form鈥�
